Competition Law and Policy in the Japanese Pharmaceutical Sector

This is the first book published that focuses on competition law and policy in the Japanese pharmaceutical sector.

Format: Paperback / softback
Length: 245 pages
Publication date: 10 February 2023
Publisher: Springer Verlag, Singapore

This groundbreaking book is the first to delve into the intricate world of competition law and policy in the Japanese pharmaceutical sector. Comprising a collection of chapters authored and meticulously edited by esteemed academics who possess diverse perspectives on the industry, including economics, competition law, pharmaceutical regulations, and intellectual property law, this comprehensive volume offers a profound exploration of the sector.

The pharmaceutical industry, characterized by its global reach and complex regulatory frameworks, garners significant attention from academics and policymakers alike. Drug laws, which vary significantly across countries, are influenced by diverse practices and industrial structures, making it a challenging terrain to navigate. The book begins by delving into the unique drug regulations and trade practices prevalent in Japan, specifically within its healthcare system. It then presents an in-depth analysis of the Japanese Antimonopoly Act, highlighting its significance and the cases that have shaped its application. Furthermore, the book delves into current competition law issues in the Japanese pharmaceutical industry, shedding light on the challenges and opportunities faced by companies in this dynamic market.

In addition to its examination of regulatory frameworks, the book also explores the realm of innovation and intellectual property in the pharmaceutical sector. It conducts economic analyses of pharmaceutical regulations and drug discovery, providing valuable insights into the economic implications of these policies. The chapters include comparative studies on Japanese regulations versus those in the European Union and the United States, offering a comparative perspective on regulatory frameworks and practices.

Japan, as one of the largest pharmaceutical markets globally, presents a unique landscape for pharmaceutical regulations. Recognizing this, the book serves as a valuable resource for anyone interested in understanding the intricacies of pharmaceutical regulations in the country. It caters to a diverse audience, including students, academics, pharmaceutical companies, regulators, and policy-makers grappling with real-world policy issues that encompass competition policy, intellectual property, and pharmaceutical regulation.

Chapter 11 of this book is made available open access under a Creative Commons Attribution 4.0 International License via the link: link.springer.com. This open access policy ensures that the knowledge and insights contained within the book are accessible to a wide range of individuals and organizations, fostering knowledge sharing and promoting the advancement of competition law and policy in the pharmaceutical sector.

In conclusion, this groundbreaking book is a must-read for anyone seeking to gain a comprehensive understanding of competition law and policy in the Japanese pharmaceutical sector. Through its diverse chapters authored by esteemed academics, it provides a rich tapestry of insights and perspectives, enabling readers to navigate the complex terrain of this industry with greater clarity and proficiency.

Weight: 415g
Dimension: 235 x 155 (mm)
ISBN-13: 9789811678165
Edition number: 1st ed. 2022